Therapeutic targets for rheumatoid arthritis: Progress and promises

A Alghasham, Z Rasheed - Autoimmunity, 2014 - Taylor & Francis
Recent therapeutic advancements in understanding of molecular and cellular mechanisms
of rheumatoid arthritis (RA) have highlighted the strategies that aim to inhibit the harmful …

p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes

R Menon, J Papaconstantinou - Expert Opinion on Therapeutic …, 2016 - Taylor & Francis
Introduction: Spontaneous preterm birth (PTB) and preterm premature rupture of the
membranes (pPROM) remain as a major clinical and therapeutic problem for intervention …

Old and new therapeutics for Rheumatoid Arthritis: in vivo models and drug development

S Sardar, Å Andersson - Immunopharmacology and …, 2016 - Taylor & Francis
Abstract Development of novel drugs for treatment of chronic inflammatory diseases is to a
large extent dependent on the availability of good experimental in vivo models in order to …

Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis

E Salgado, JR Maneiro, L Carmona… - Annals of the …, 2014 - ard.bmj.com
Objective To summarise the adverse events (AE) reported in patients with rheumatoid
arthritis (RA) treated with protein kinase inhibitors (PKi), and identify family and molecule …

Lack of the T cell–specific alternative p38 activation pathway reduces autoimmunity and inflammation

L Jirmanova, ML Giardino Torchia… - Blood, The Journal …, 2011 - ashpublications.org
Stimulation via the T-cell receptor (TCR) activates p38α and p38β by phosphorylation of p38
Tyr-323 (p38Y323). Here we characterize knockin mice in which p38α and/or β Tyr-323 has …

Anti-arthritic effects of clematichinenoside (AR-6) on PI3K/Akt signaling pathway and TNF-α associated with collagen-induced arthritis

W Han, Y Xiong, Y Li, W Fang, Y Ma, L Liu… - Pharmaceutical …, 2013 - Taylor & Francis
Context: Clematichinenoside (AR-6) is a triterpene saponin from an anti-arthritic herbal
formula Wei-Ling-Xian in Chinese, which is an herbal medicine derived from the dried root …

Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD)

IM Adcock, J Marwick, P Casolari… - Current …, 2010 - ingentaconnect.com
Inhaled glucocorticoids, also know as corticosteroids (ICS), revolutionized the treatment of
asthma by suppressing airways inflammation and ICS therapy now forms the basis of …

Optimization of α-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric site

AG Montalban, E Boman, CD Chang, SC Ceide… - Bioorganic & medicinal …, 2010 - Elsevier
We have optimized a novel series of potent p38 MAP kinase inhibitors based on an α-
ketoamide scaffold through structure based design that due to their extended molecular …

p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies

RP Gangwal, A Bhadauriya, MV Damre… - Current topics in …, 2013 - ingentaconnect.com
p38 mitogen-activated protein (MAP) kinases are the serine/threonine protein kinases,
which play a vital role in cellular responses to external stress signals. p38 MAP kinase …

p38 mitogen-activated protein kinase is not activated in the quadriceps of patients with stable chronic obstructive pulmonary disease

J Riddoch-Contreras, T George… - COPD: Journal of …, 2012 - Taylor & Francis
Quadriceps weakness is associated with a poor prognosis in COPD. Several data suggest
that immobility and muscle wasting may be related through up-regulation of the p38 Mitogen …